LG Chem Holds Symposium to Commemorate Launch of 'Bellacolin' for Submental Fat Improvement

LG Chem announced on the 8th that it held a symposium commemorating the launch of Bellacolin, an injection for improving submental fat, targeting about 70 domestic cosmetic surgery medical professionals.

A symposium celebrating the launch of LG Chem's submental fat reduction injection 'Bellacolin' is taking place.
[Photo by LG Chem]

Bellacolin is a deoxycholic acid-based agent, a representative fat-dissolving ingredient, and received approval from the Ministry of Food and Drug Safety in January to be sold as a prescription drug for improving moderate to severe protruding or excessive submental fat in adults.

At the symposium, So Jin-eon, Head of LG Chem CMC Research Center (Executive Director), gave the first presentation, stating, "The quality factors of the product can affect the degree of pain after the procedure," and added, "Bellacolin’s competitiveness lies in applying a pH similar to that of the human body and minimizing the possibility of precipitate formation through a differentiated manufacturing process." Clinical results of the same deoxycholic acid ingredient formulation overseas were also shared. The clinical results confirmed a statistically significant improvement of one or more levels in submental fat in 68.2% of the deoxycholic acid treatment group three months after the final administration. Improvement was observed in 20.5% of the placebo group. Additionally, clinical literature was presented confirming that the submental fat reduction effect was maintained even after one year.

Following this, Professor Han Seung-ho of Ewha Womans University Seoul Hospital gave an in-depth lecture on the anatomy of the submental area, explaining anatomical structures that require caution for safety and providing procedural insights. Dr. Jang Ji-yeon, Director of Vance Clinic Sinsa Branch, shared the unique advantages and effective procedural methods of Bellacolin for jawline improvement under the theme "Contour Procedures with Bellacolin."

No Ji-hye, Head of LG Chem’s Aesthetic Business Division, said, “Bellacolin will be the optimal choice for customers who want a clear contour,” and added, “We will continue to provide solutions based on customer needs and strive to become a global leader in medical-aesthetic innovation.”

This content was produced with the assistance of AI translation services.